Showing results (1-10 of 102) with videos related to
Sort By:
Pageof 11
Rheumatology (Oxford, England)|November 18, 2004
Calcium channel blockers for primary Raynaud's phenomenon: a meta-analysisA E Thompson, J E PopeBritish Journal of Rheumatology|February 11, 1999
A study of the frequency of pericardial and pleural effusions in sclerodermaA E Thompson, J E PopeArthritis and Rheumatism|August 18, 2001
Calcium-channel blockers for Raynaud's phenomenon in systemic sclerosisA E Thompson, B Shea, V Welch, et al.Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|December 17, 2008
Antimitochondrial antibodies and their significance in diffuse and limited sclerodermaJ E Pope, A ThompsonClinical and Experimental Rheumatology|March 10, 2011
The minimally important difference (MID) for patient-reported outcomes including pain, fatigue, sleep and the health assessment questionnaire disability index (HAQ-DI) in primary Sjögren's syndromeA George, J E PopeSeminars in Arthritis and Rheumatism|August 1, 1993
Outcome measurement in scleroderma clinical trialsJ E Pope, N BellamyClinical and Investigative Medicine. Medecine Clinique Et Experimentale|February 1, 1995
Sample size calculations in scleroderma: a rational approach to choosing outcome measurements in scleroderma trialsJ E Pope, N BellamyJournal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|December 17, 2008
A case of erythema nodosum with arthritisJ E Pope, D McCormackThe Journal of Rheumatology|June 14, 2000
The frequency and significance of anticardiolipin antibodies in sclerodermaJ E Pope, A ThompsonPageof 11